September 6, 2012 — Drug-eluting stents (DES) are used less often in women treated with percutaneous coronary ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.Â
August 22, 2012 — Placement of an endovascular stent has become a common procedure for successfully reopening blocked ...
August 22, 2012
August 20, 2012 — Abbott today announced that the Xience Xpedition everolimus-eluting coronary stent system received CE ...
August 20, 2012Sponsored Content
Case Study | Baylor Scott and White Heart Hospital
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
May 05, 2023
August 15, 2012 — Previously unreleased three-year data from the Zilver PTX randomized controlled trial of paclitaxel ...
August 15, 2012August 14, 2012 — The U.S. Food and Drug Administration (FDA) is hosting a public workshop that examines use of ...
August 14, 2012August 9, 2012 — The U.S. Food and Drug Administration (FDA) is informing healthcare providers and patients that the ...
August 09, 2012
Aug. 8, 2012 — The U.S. Food and Drug Administration (FDA) has approved Abbott’s Omnilink Elite Vascular Balloon ...
August 08, 2012July 17, 2012 — Arterial Remodeling Technologies (ART) reported that they have achieved a medical milestone with its ...
July 17, 2012
Feature | Kamran Zamanian, Ph.D.
Â
As the average age of the U.S. population and the number of patients at high risk for cardiovascular disease ...
July 17, 2012
July 16, 2012 — Reva Medical Inc. announced it completed clinical enrollment with the ReZolve drug-eluting bioresorbable ...
July 16, 2012July 12, 2012 — Terumo Interventional Systems, a strategic business unit of Terumo Medical Corporation, a U.S ...
July 12, 2012July 3, 2012 — Flexible Stenting Solutions Inc., a leading developer of next generation peripheral arterial, venous ...
July 03, 2012June 21, 2012 — Plans for a new study involving BioFreedom, the polymer-free drug-coated stent (DCS) from Biosensors ...
June 21, 2012June 15, 2012 — Stentys SA, a medical technology company commercializing the world's first and only self-apposing stent ...
June 15, 2012
Feature | Gavin Hays, CEO, Springboard Inc.
Evaluating the performance of your cath lab is key to developing a strategic plan for improving service offerings ...
June 05, 2012© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now